Vildagliptin for early Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if vildagliptin, a medication for diabetes, can help people with early-stage Parkinson's disease. It is looking for patients diagnosed within the last three years who are on stable Parkinson's medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You were diagnosed with Parkinson's disease less than 3 years ago
- You have been on a steady dose of your Parkinson's medications for at least 1 month
- You do not have advanced Parkinson's with balance problems or medication-related 'on-off' fluctuations
- You do not have diabetes or have not taken vildagliptin or similar drugs before
- You have no severe memory problems (score above 18 on a memory test)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet (VG081821AC) for people with early-to-mid-stage Parkinson's disease who have not recently used levodopa. The goal is to see if it can improve movement symptoms safely.
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
This study tests an investigational drug to see if it can help people with early Parkinson's disease. It may offer a new treatment option to manage symptoms.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
Hear when a new Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.